ClearPoint Neuro
CLPT
103 hedge funds and large institutions have $97.5M invested in ClearPoint Neuro in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 11 closing their positions.
904% more call options, than puts
Call options by funds: $3.65M | Put options by funds: $364K
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
55% more capital inflows, than outflows
Capital inflows: $25.9M | Capital outflows: $16.7M
14% more funds holding
Funds holding: 90 → 103 (+13)
2.09% more ownership
Funds ownership: 27.57% → 29.65% (+2.1%)
9% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 32
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$7.03M |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$2M |
| 3 |
Goldman Sachs
New York
|
+$1.99M |
| 4 |
Lane Generational
Dover,
Massachusetts
|
+$1.31M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$3.81M |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
-$1.79M |
| 3 |
Essex Investment Management
Boston,
Massachusetts
|
-$1.26M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.11M |
| 5 |
Jane Street
New York
|
-$1.02M |
CLPT Hedge Fund Activity: Q1 2025 in Review
103 of the 7,489 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2025, worth a combined $97.5M — down 17% from $117M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CLPT positions and 11 closed out — a net gain of 13 holders — while 29 added to existing stakes and 32 trimmed.
The largest buyer was Millennium Management, adding an estimated $7.03M. The largest seller was Invesco, exiting entirely with an estimated $3.81M sold.
- 103 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2025, up from 90 in Q4 2024.
- Funds reported $97.5M of ClearPoint Neuro stock for Q1 2025, down 17% quarter-over-quarter.
- 24 funds opened new ClearPoint Neuro positions in Q1 2025 and 11 closed out, a net change of +13 holders.
- The largest ClearPoint Neuro buyer in Q1 2025 was Millennium Management, an estimated $7.03M added.
- The largest ClearPoint Neuro seller in Q1 2025 was Invesco, an estimated $3.81M sold.
Based on aggregated 13F filings for Q1 2025.